Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
Active, not recruiting
- Conditions
- Prostate Cancer
- Registration Number
- NCT01514669
- Lead Sponsor
- University of Arkansas
- Brief Summary
The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 75
Inclusion Criteria
- Male, 35-85 years old
- Patients who present for the evaluation of an abnormal exam or test (elevated PSA, abnormal DRE, etc.)
- Patients who present for the evaluation of a palpable nodule or induration on prostate exam
- Patients who meet the requirements of Group 1, 2, or 3 of the protocol
Exclusion Criteria
- Patient < 35 or > 85 years of age
- Concurrent eye infection or trauma, including active conjunctivitis
- Abnormal production of tears (too much or too little)
- Any other conditions the PI or staff feels will not fulfill the criteria for study entry or will place the subject in a harmful environment
- Atypia on prostate biopsy report
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tear Sample 1 day Tear sample will be taken at the initial clinic visit
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
University of Arkansas for Medical Sciences
🇺🇸Little Rock, Arkansas, United States